Differential protein expression profiling by iTRAQ‐2D‐LC‐MS/MS of rats treated with oxaliplatin
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.29116
Abstract: Clinical application of oxaliplatin, a platinum‐based chemotherapeutic agent, in cancer, especially colorectal cancer, is widely used. However, oxaliplatin‐induced peripheral neurotoxicity (OIPN) has a high incidence, and to date, there have been few detailed studies on… read more here.
Keywords: protein expression; rats treated; differential protein; expression ... See more keywords
The Role of the Carnitine/Organic Cation Transporter Novel 2 in the Clinical Outcome of Patients With Locally Advanced Esophageal Carcinoma Treated With Oxaliplatin
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.684545
Abstract: Esophageal cancer is the ninth most common malignancy worldwide, ranking sixth in mortality. Platinum-based chemotherapy is commonly used for treating locally advanced esophageal cancer, yet it is ineffective in a large portion of patients. There… read more here.
Keywords: expression; carnitine; cancer; treated oxaliplatin ... See more keywords